Using generative AI to identify potent and selective MYT1 inhibitors for the treatment of cancer
Recent research has identified MYT1 as a promising new therapeutic target for breast and gynecological cancer and discovered a series of novel, potent, and highly selective inhibitors specifically targeting MYT1.